MapLight Therapeutics, Inc. (MPLT)
27.40
-1.80
(-6.16%)
USD |
NASDAQ |
May 08, 16:00
27.30
-0.10
(-0.35%)
After-Hours: 20:00
MapLight Therapeutics Shareholders Equity (Quarterly) : 458.37M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Liminatus Pharma, Inc. | -9.815M |
| Oruka Therapeutics, Inc. | 471.93M |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | 1.344B |
| Insight Molecular Diagnostics, Inc. | -31.46M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 479.51M |
| Total Liabilities (Quarterly) | 21.14M |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 20.01 |
| Net Debt Paydown Yield | 0.00% |